生物标志物 生物标志物
Belen Pascual1, Alireza Faridar1, Quentin Finn1
1Houston Methodist Research Institute, Houston, TX, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
干白素-2免疫疗法改善了阿尔茨海默病的生物标志物和认知功能,但转位蛋白 (TSPO) PET成像没有改变. 未来的研究可能需要新的PET标记剂来检测炎症.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 放射化学 放射化学是指辐射化学.
背景情况:
- 转位蛋白 (TSPO) PET成像通过向微质细胞和巨细胞来评估大脑炎症.
- 目前的TSPO PET标记器无法区分促炎 (M1) 和抗炎 (M2) 微质表型.
- 在针对炎症的阿尔茨海默病 (AD) 临床试验中,TSPO PET的实用性尚未得到充分研究.
研究的目的:
- 用C-ER176 TSPO PET在阿尔茨海默病患者的免疫调节性Interleukin-2 (IL-2) 临床试验前后评估大脑炎症的变化.
- 评估IL-2免疫治疗对T调节 (Treg) 细胞种群,脑脊液 (CSF) 生物标志物和认知功能的影响.
主要方法:
- 一个2a期,随机,双盲,安慰剂对照试验,涉及38名AD患者 (50-86岁).
- 参与者每4周接受IL-2 (IL-2 q4wks),每2周接受IL-2 (IL-2 q2wks) 或21周接受安慰剂.
- 在治疗前和后进行了C-ER176PET扫描,脑脊液/血液生物标志物和临床评估.
主要成果:
- 在所有组中都没有观察到TSPO PET结合的显著变化.
- 两种IL-2疗法都增加了Treg数量和功能;IL-2 q4wks显示出更大的疗效.
- 与安慰剂相比,IL-2 q4wks组在CSF Aβ42和趋势向稳定的CSF NfL显著改善,GFAP水平降低.
- 与安慰剂相比,IL-2 q4wks组观察到认知衰退的减缓.
结论:
- 在 q4wks 频率的 IL-2 免疫疗法增强了 Treg 种群,并显示了 AD 生物标志物和认知功能的有前途趋势.
- 使用C-ER176的TSPO PET成像在21周的试验中没有检测到大脑炎症的显著变化.
- 未来的AD临床试验可能会从更长的随访,更大的样本大小或针对特定免疫细胞表型 (M1/M2巨细胞) 或其他炎症途径的新型PET标记物中获益.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


